OSCR Earnings Beat Setup LONGOSCR on the daily chart is shown near to but below the POC line on the volume
profile anchored in April. The ZL MACD has a low amplitude histogram. On
the directional index indicator both negative and positive lines are nearly trendless
at the 20 level. The price is closer to the lower Bollinger Bands and so a reversion
to the mean would be upward price action.
I am looking to take a long trade here. The entry would be by a buy stop over
the POC line at 7.35 and the stop loss at 7.05, the low of the last red candle.
The targets are 8.75 and 9.85 corresponding to horizontal resistance lines.
This is a swing trade planning for a profit of about 30%. The stop loss of 0.30
as compared with an average target of 1.75 is about 1:5 for the risk to reward.
I may take an options trade of 1-3 months duration as well. Leave a commnet , if
you would like to know my considerations for a call option. Healthcare and medical
are relatively strong sectors right now compared with the chaotic market at large.
Healthcarestocks
CVAC - Trade Opportunity Looking through charts, CVAC caught my eye for some potential trade opportunities.
Firstly lets look at the candle close of Today 08/01/23
-> We are currently testing this RED Resistance Arrow Line pointing down
-> The candle has a lower wick, indicating some buying pressure
->However, the candle body is small, which may indicate waning momentum
**If price action CONFIRMS above RED ARROW -> This can be a TRADE SETUP
-> If this plays out - TARGET = $10.65 or a potential 17% move
-> STOP LOSS should be placed below RED ARROW
Notice the GREEN circle indicating a bounce UP from 2 converging support lines
-> The 200 DMA -> this is important as if we maintain support on 200 DMA, it indicates Bullish activity, price has a possibility of traveling back to UPPER BLACK RESISTANCE LINE
BUT NOTE: This is the first time for CVAC to be doing this, so we have to be cautious, as FAKEOUTS are possible.
-> The orange sloping support line
~~ Having 2 support lines converge makes SUPPORT two-folds stronger, which may create ncessary momentum for price to break above RED ARROW
Now Notice how the ORANGE SUPPORT LINE coincides with the ORANGE line found on the RSI and MACD
-> This is known as a BEARISH DIVEGENCE -> Where price shows a higher low but Indicators show lower lowers.
-> This leads to PRICE DECLINES if it plays out, may lead Price Action to go towards the BLACK Support line or where the RED ARROW is pointing at.
-> Its also not necessary that it plays out right away, we can technically hit my TARGET of $10.65 and then have the DIVERGENCE play out.
*** Regardless of what happens, BLACK SLOPING SUPPORT LINE can be a BUY ZONE with STOP LOSS BELOW this line. This would be to catch a bounce off this line.
RSI orange line MUST stay above or act as SUPPORT on the BLACK moving average, this normally leads to PRICE increasing
MACD (Momentum indicator)
-> must continue this histogram pattern of waning bearish momentum, we must print GREEN histogram.
-> There needs to be a BULLISH CROSS where BLUE line crosses above the ORANGE line.
-> This would help us breakout of the RED ARROW RESISTANCE
STOCH RSI
-> BLUE line has CROSSED over ORANGE, and we are ABOVE the 20 level. This indicates BULLISH MOMENTUM.
-> We must continue UPWARD above the 80 level, this indicates continuation of MOMENTUM, if we keep this direction -> It may HELP us BREAKOUT of RED ARROW RESISTANCE LINE.
CONCLUSION:
All in all, we are in a interesting area for CVAC the stock. New things are happening in the price action, that has not been seen in the history of CVAC. 200 DMA acting as support for the 1st time, STOCH RSI Bullish cross and waning of bearish momentum in MACD can be the necessary catalyst to push PRICE above the RED ARROW RESISTANCE. If so TARGET = $10.65 or a 17% Trade. However, it is important to note the BEARISH DIVERGENCE forming, though a sign of DOWNWARD PRICE ACTION, can also lead to opportunity of a trade setup. Never fight the trend, its always better to ride along.
Thanks you! Hope this helps, please support my ideas by boosting, following and commenting! Do check out my page of other trade ideas. I have linked a couple of recent ideas ive had, check em out if you'd like.
DISCLAIMER: This is not Financial advice, i am NOT a Financial advisor. Thoughts expressed here are my only my opinion and for educational purposes. Do practice due diligence and focus on risk mamangement. Deploy stop losses to protect yourself. Thanks.
TDOC - Update after a Bullish WeekIve been eyeing TDOC for some time, finally posting a chart on it talking about TA developments that may indicate a potential bottom area earlier this week (Check below for the link to that chart). I was also in the camp of TDOC going lower to the low $20 or high Teens ($18-19).
This weeks move of 30%, closing the weekly candle at 20% gains was a wonderful surprise.
Its important to NOTE, however that the move is NOT SET IN STONE yet -> For WEEKLY Timeframe
We are hitting a MAJOR confluence of RESISTANCES. Though we are ever so peaking our head out atm, next 1-2 weeks will show more evidence with confirmation.
FOr example: Next week CLOSE being a bullish single candle or next couple weeks printing a bullish candlestick pattern sequence.
The other side is that It could very well be a fake out/ SELL OFF and we do come back down to make a final lower low before we really become bullish. But in my opinion, the probability of a fake out maybe less.
We've moved above the 21 week EMA as well, we would need to confirm support above it in the coming weeks but being above 21 EMA indicates bullish activity.
NOTICE the Bollinger bands. Notice how it has narrowed, this could indicate volitility to pick up and we need to see price stay above median line and be near the upper band. We must Observe what happens in the coming weeks.
The Bollinger median line and 21 EMA are converging and can act as strong support zone. If we do come back down in price.
On the DAILY timeframe, we acted as SUPPORT on both the PURPLE major RESISTANCE line from all time highs and RESISTANCE line from July 2022. Just note however i would need more confirmation in the coming days by staying above as support, to be confident we stay at these levels. If we do, next weeks candle stays above and no fakeout occurs.
RSI is breaking out of the Horizontal resistance line that kept RSI range bound since OCT 2021. (indicated by black line)
This tells me, the BULLISH DIVERGENCE is at play. We would want RSI to continue UP, or follow the Green arrowed path drawn. We absolutely do NOT want the Red arrow. Which is a possibility but less probable in my opinion.
STOCH RSI, a momentum indicator shows that we have a bullish momentum cross, showing that there is still gas left in the tank for us to move. Expect it to go above the 80 level.
Conclusion + trade setups:
For stocks that are 80+% off there tops, averaging in always is a nice strategy.
I think under $30 is cheap for TDOC, especially with all these TA challenges being slowly conquered. There is no denying that it is highly probable we go up eventually, as we've reached critical historical support, and have been consolidating around here for awhile. Alot of indicators and other signs are leaning towards a bottom being formed or already formed.
*CHECK OUT A more detailed TDOC chart from earlier this week BELOW*
A swing trade idea could be taking positions using the Daily timeframe, putting stop loss below the PURPLE line. Making sure you manage your risk properly.
I would rely more on the WEEKLY timeframe and a confirmation that we've made it above the resistance, plus weekly candles are more macro and powerful. This would also be for holding/ longer term investing.
THANK YOU! Hope this update helped. If you like the content, please boost and follow. Please do comment with your opinions! Would love a discussion.
DISCLAIMER: I am not a Financial advisor. This is NOT financial advise. This is my opinion and for educational purposes.
TDOC - Teladoc bottom fishingHello. This chart is strictly a Technical Analysis of Teladoc (TDOC).
I think currently we are in a point in TDOC's price action where we've reached a fundamental SUPPORT area if you look back to 2016. This could potentially be opportune BUY ZONE.
TA is all about probability. The probability we go down is always there, just in this scenario i believe the probability of downside is less compared to the upside.
Though i want some short term downside for TDOC, as i believe that would be the necessary catalyst to help shift trend to upside. Price will eventually rally up, especially if we are in a bull market currently. Which i believe we are in. Ill go into details on why i want it and believe this.
NOTE: This is on the WEEKLY timeframe, so we are looking into a more macro scenario than if we were to look at DAILY timeframe.
LAST WEEk -> We printed a candle that has a large upper wick, indicating SELLING pressure.
We are also resting right on top of a major support level at around $23, indicated by green horizontal like.
It wouldnt be bad for price to drop below and touch the lower 2 green lines, the sloping one and horizontal one. This would be a catalyst due to price action then, starting to confirm what is known as a BULLISH DIVERGENCE.
Which is a pattern or concept where PRICE ACTION forms LOWER LOWS, as INDICATORS create HIGHER LOWERS -> Seen by the white sloping line drawn in the RSI and MACD. And the green sloping line in PRICE ACTION indicates the lower lows.
*Many trades ive recently taken have followed similar patterns, ill link 1 chart to compare this to BELOW* Its for stock LMND. Heres also a SNAP SHOT.
NOTICE the horizontal white line on RSI -> this is what helps me guage at when this move and UPSIDE can start or hit. If RSI breaks out above this line, we can start to see BULLISH DIVERGENCE playout. Easily i can see TDOC hitting around the $40.00 level.
Going back to CURRENT price action. I believe we go down and test the lower green lines, because of all this RESISTANCE that we are facing.
NOTICE:
#PURPLE SLOPING RESISTANCE LINE -> This is MAJOR MAJOR resistance, created since Feb 2021. We just tested it for the 3rd time, last week. (Note: atleast 3 touches are required to weaken lines, more price touches lines -> the weaker they get.)
# We also got some short term WHITE SLOPING RESISTANCE LINES. Helping to push price down
# We also got the 21 EMA (YELLOW Moving average)
******Note, all these are meeting together to act as RESISTANCE. When theres so many converging, like this -> It gets a little hard or takes time to break through to upside.
***ALso i think the PURPLE line is MOST IMPORTANT. This would help reverse trend in a major macro way.
SO KEEP OBSERVING.
Lastly, note the ADX & DI -> This is a momentum indicator. When RED line is over Green line, it indicates BEARISH Price action, as you can see by the downtrend. Currently there is some green overlapping occuring. We have to keep observing to see how this progresses. But ideally, we'd like to see Green shoot up to above 20 level, just like the red line did in white box.
CONCLUSION: I believe in the short term, we could have some downside price action coming. But sometimes, downside action could have positive ramifications. In this case, further strengthening the BULLISH DIVERGENCE forming in the charts. Indicators and current support area, indicate seller exhausting. Probabilities in my opinion point to price moving up than down. Hitting either one of the lower green support lines, could be areas where positions can be taken with stop losses set below.
DISCLAIMER: This is by NO MEANS, Financial advice. I am not a financial advisor, im just a TA nerd and post these for educational purpose. Always follow your own due diligence when trading/investing. Always focus most of your energy on risk management strategies.
If you like this content, please do BOOST, FOLLOW and do COMMENT, i would like others opinions on what your seeing, whether TA or FA. Thank you.
$PINC Punished for Lack of Working Capital?Premier health seems to be flashing some hands off signals at the moment.Based on an analysis of earnings against potential growth, fair value for NASDAQ:PINC would be around $40.38, but the stock is trading 54% below that target. They are even trading below the average analyst target of $33.40. These are signs that something is weighing on the market value of the firm.
Potential Issues for Investors Include:
1. Cash to Equity at 4%: This suggests that the company has an insufficient amount of cash to fuel growth and handle liabilities. I would direct investor attention to the company's negative working capital and 20% drop in operating cash flows.
2. Shareholder Dilution: Premier seems to be constantly issuing new shares, which negates any market value that could be had from an increase in earnings.
3. Net Cash Negative: Total debt held by the company is down trailing 12 months, but still leaves the company with -$3.31 net cash per share over that same time period.
Key Point: The company is over leveraged amidst tight financial conditions and margins in the healthcare space are dropping like a hot rock. This draws concern as the company has been working with negative working capital for 5 straight years.
To mention a few bright spots, the company generating $84 in free cash flow for every $100 in earnings and seems to at least over the past 12 months be looking to reduce their debt. The company is projected to see earnings growth of 5.6% over the next 5 years, but is priced for no growth.
Investors who look at this as a mispricing and buy today could see a push toward our forward looking valuations. This could yield as much as a 55% increase in the stock price. On the other hand the key question would be; can the company survive long enough to fix the problems?
Investors who believe they will survive can look at this as a reasonable opportunity to buy ahead of any capital appreciation.
Earnings are steady over the long term with over 4,400 member hospitals in their circle which should keep the money coming in.
Worst case scenario, they become an acquisition target down the line, but in the mean time, I the market is sending signals that hands off is the policy.
No growth value is definitely an enticing price point, but maybe a look at next quarter's earnings could provide more insight on the company's direction.
PINC faces increased competition from other healthcare improvement companies, such as Optum and UnitedHealth Group. These companies are investing heavily in new technologies and solutions, which could put pressure on PINC's margins.
PINC also faces a number of regulatory challenges, such as the implementation of the Affordable Care Act and the rising cost of healthcare. These challenges could make it difficult for PINC to grow its business and maintain its profitability.
Income and cash flows have taken a step down in 2023. Cash flows are projected to continue to decline in 2024 and return to growth in 2025.
VERO Bullish Momentum Share Price SplitVERO recently underwent a stock price 15:! split. Venus Concept, Inc. develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related practice enhancement services. Its product portfolio consists of aesthetic device platforms which includes venus versa, venus legacy, venus velocity, venus fiore, venus viva, venus freeze plus, and venus bliss. The company was founded on November 22, 2002 and is headquartered in Toronto.
On the chart, VERO is shown to have a downward trajectory for some years. Howwver, volume
spikes are seen 5-10X relative to near term historical volume. The RSI indicator suggests bullish
divergence for about a month. Finally, price action went parabolic after the split and makes
VERO a bullish continuation candidate.
I will take a partial long position immediately while also waiting for a pullback to supplement
the initial partial position.
Afrocentric breakaway and up and away to R5.93W Formation formed on Afrocentric. The price broke above the neckline showing there's more demand.
Before that there was a big GAP. This gap is known as a breakway away.
It broke out of the down/sideways trend and into an uptrend.
Hence there is a bullish tone and more buying along the way.
7>21>200
RSI>50
Bullish
Target R5.93
ABOUT
AfroCentric Investment Corporation Limited (Founded in 2008) is a South African healthcare company listed on the Johannesburg Stock Exchange.
Their goal is to provide affordable, accessible healthcare to all South Africans.
They operate through three main subsidiaries: Medscheme, Pharmacy Direct, and AfroCentric Health.
Medscheme is one of South Africa's leading medical scheme administrators, managing over 3.5 million lives across multiple medical schemes.
Pharmacy Direct is a retail pharmacy network that operates in several provinces across South Africa, offering a range of healthcare products and services.
AfroCentric Health provides a range of healthcare services, including primary healthcare, occupational health, and wellness programs, to individuals and corporations.
Nasdaq Up 4% After Dovish Fed CommentsSeveral tech & healthcare sector stocks making an early bullish run such as AMD, KLA and DXCM after a dovish Federal Reserve comments on slowing down interest rates hike. However, Fed mentioned interest rates may floating around the 5% level until they see interest rates remain low within the next quarter.
UnitedHealthGroup Analysis 19.11.2022Welcome to the BasicTrading channel.
My name is Philip and in todays analysis I quickly go over the situation which we currently have on UnitedHealth Group.
I will analyse the asset both from a weekly and daily timeframe to show you the best possible trading opportunities.
If you enjoyed this analysis, let me know in the comment section which asset I should analyse tomorrow.
I will personally reply to every single comment.
Dont forget to smash that rocket and I will see you tomorrow with a new analysis.
UNITED HEALTH Stronger than ever one last Resistance to go!The UnitedHealth Group (UNH) has been on a strong 3 day rise since the November 15 Low which was a Higher Low within a hyper long-term Bullish Megaphone pattern, with the trend-line holding since February 22 2021. On top of that it rebounded within the 1W MA50 (red trend-line) - 1D MA200 (orange trend-line) zone, which has more or less priced all prior major Higher Lows.
The next barrier standing is the 553.00 - 559.00 Resistance Zone that is holding since the April 14 2022 High and has had another two rejections, forming an Ascending Triangle. Needless to say, a break above it would be a major bullish break-out signal. As to the target? That would be initially the 1.382 Fibonacci extension, around $590.00, which is the symmetrical of the Fibonacci retracement levels that have formed the last two Higher Lows. As seen on the chart, the November 15 2022 Low was made on the 0.5 Fib while the October 13 2022 on the 0.382 Fib. We can argue that if there is one more rejection on the Resistance Zone, then the 0.618 Fib is a candidate for the next Higher Low.
-------------------------------------------------------------------------------
** Please LIKE 👍, SUBSCRIBE ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support me, keep the content here free and allow the idea to reach as many people as possible. **
-------------------------------------------------------------------------------
You may also TELL ME 🙋♀️🙋♂️ in the comments section which symbol you want me to analyze next and on which time-frame. The one with the most posts will be published tomorrow! 👏🎁
-------------------------------------------------------------------------------
👇 👇 👇 👇 👇 👇
💸💸💸💸💸💸
👇 👇 👇 👇 👇 👇
UNH: Can trend line hold bears?United Health Group
Short Term - We look to Buy a break of 506.00 (stop at 485.43)
The primary trend remains bullish. A sequence of daily higher highs and lows has been posted. We can see no technical reason for a change of trend. Trend line support is located at 500.00. Further upside is expected.
Our profit targets will be 558.58 and 580.00
Resistance: 560.00 / 580.00 / 600.00
Support: 500.00 / 450.00 / 400.0
Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’) . Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
CTLT: Bottoming out?Catalent
Short Term - We look to Buy at 63.84 (stop at 56.95)
The primary trend remains bearish. Bespoke support is located at 63.30. Support could prove difficult to breakdown. We look for a temporary move lower. Preferred trade is to buy on dips.
Our profit targets will be 82.27 and 88.00
Resistance: 82.50 / 100.00 / 120.00
Support: 63.30 / 48.00 / 30.00
Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’ ). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
GE: Double Bottom?!General Electric Company
Short Term - We look to Buy at 72.25 (stop at 68.61)
Posted a Double Bottom formation. This is positive for sentiment and the uptrend has potential to return. A weaker opening is expected to challenge bullish resolve. Support is located at 70.00 and should stem dips to this area. Dip buying offers good risk/reward.
Our profit targets will be 81.26 and 83.00
Resistance: 81.50 / 96.00 / 108.00
Support: 70.00 / 60.00 / 44.00
Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
10/23/22 HUMHumana Inc. ( NYSE:HUM )
Sector: Health Services (Managed Health Care)
Market Capitalization: 64.611B
Current Price: $510.54
Breakout price trigger: $515.20
Buy Zone (Top/Bottom Range): $496.45-$473.95
Price Target: $562.30-$568.90
Estimated Duration to Target: 147-156d
Contract of Interest: $HUM 1/20/23 520c
Trade price as of publish date: $26.20/contract
CI: Break all time highs?CIGNA CORPORATION
Short Term - We look to Buy a break of 296.00 (stop at 288.02)
Price action continues to trade around the all-time highs. There is no sign that this bullish momentum is faltering but the pair has stalled close to a previous swing high of 294.50. The bias is to break to the upside. A break of resistance at 296.00 should lead to a more aggressive move higher towards 315.00.
Our profit targets will be 315.00 and 320.00
Resistance: 294.50 / 315.00 / 400.00
Support: 283.50 / 271.00 / 240.00
P lease be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’) . Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
10/5/22 RVNCRevance Therapeutics, Inc.( NASDAQ:RVNC )
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $2.124B
Current Price: $29.17
Breakout price: $30.00
Buy Zone (Top/Bottom Range): $27.45-$24.15
Price Target: $41.10-$42.00
Estimated Duration to Target: 132-142d
Contract of Interest: $RVNC 1/20/23 30c
Trade price as of publish date: $3.70/contract
ABBV up;respecting wma50 despite LABU biotech 3x etf falling 10%ABBV is one of Warren Buffet’s holding in BRK.B. It has been respecting the weekly wma50 for a long time while holding an uptrend.
I think the sentiment has been too bearish & a shortterm rebound in the general market is due in the next few days.
Not trading advice.3
Veeva SystemsThis is a daily chart of Veeva Systems (VEEV), a healthcare technology company that provides cloud solutions for the global life sciences industry.
When the company reported its earnings on August 31st the stock price subsequently gapped down, as shown in the chart above. From a probability standpoint, this gap is likely to be filled for the reasons below.
1. The gap is a monthly candle gap and these usually close.
Unfilled gaps on the monthly charts are generally quite rare, especially for assets that have never left a monthly gap before. As shown in the chart below, VEEV has never left a gap on its monthly chart before.
2. The gap is below the lower regression channel line. A regression channel is used to measure how far above or below an asset is trading from its mean. Since price generally tends to mean revert, it's highly unlikely that a gap below the lower channel line, (which in this case represents two standard deviations below the mean), will never be filled. It's more likely that the gap will not only be filled, but will be filled quite rapidly. The assumption I make in using this regression channel is that it is statistically valid and data are normally distributed. If true, then there's only a small probability that VEEV's monthly candle will close the month so far below the lower line of the regression channel. Therefore, it's likely that price will be drawn back up to the mean, and thus the gap will be filled.
Here's a close up view:
3. Price gapped below an important Fibonacci level that has been holding, and likely will continue to hold, as support. See the chart below.
Here are some close up views:
At a minimum, price will very likely push back into the 180s.
The quarterly chart shows long lower wicks at this Fibonacci level, indicating that it is holding as support. With further momentum to the downside waning as shown by the Stochastic RSI, there's little reason to believe this Fibonacci level will fail this time.
The lower wicks on the quarterly candles are also bouncing off of the exponential moving average (EMA) ribbon, which usually acts as support when price descends to it from above.
Strategy
With this said, I noticed that someone is already sweeping the call options. They swept hundreds of out-of-the-money (OTM) call options expiring on 9/16 with a $180 strike. Clearly, this buyer believes that VEEV's price is poised to quickly return at least to the Fibonacci support level of $180.97.
If you don't know what an options sweep is, it simply refers to an instance in which options are purchased right at the ask price. In most cases, buyers place a limit buy at the mid point of the bid-ask spread or at a lower target price. Market participants usually only buy at the ask price if they're in a rush to buy and/or if they have a high confidence about a certain market move and want to guarantee their entry while also not tipping the market off about their anticipated market move. Sweeps can also refer to when a large buyer wants to obfuscate their entry by splitting their large order into a lot of smaller parts to sweep the entire order book without tipping off the market as they would have if they placed a single large limit order. Understanding sweeps can help you understand what smart money is doing. It's very rare that retail traders sweep the order book because it's very expensive, and for a smaller portfolio (less than a million) it can be extremely risky. Therefore, smart money is usually the market participant who sweeps the order book.
Personally, I find this call sweep to be risky (assuming that it's not part of some kind of a hedge) since although we have a high confidence that the gap may close, we don't know within what time frame it will do so. Rather than sweeping a call option with a strike price of $180 that expires on 9/16 a safer though less lucrative trade would be to sell a cash-secured put with a strike price of $180 and which expires on 9/16. Doing this gives you much higher odds of winning but is profit limited.
If the price goes to $180 or higher at expiration, you win the full premium since the put you sold will not be exercised.
If the price is below $180 but above the breakeven price at expiration, or if the price is below even your breakeven price, then you may be forced to buy shares of VEEV at $180, but you can simply hold those shares until the gap closes (or longer if you think price is going higher). Therefore in this case you still do not lose money, and still make the premium as profit.
The only plausible scenario whereby you would lose money would be if VEEV's price continued to plummet and never recovers. Although this would be incredibly unlikely, it is still possible. You can nonetheless still hedge against even this risk by using a put spread to limit loss potential to a ratio that meets your risk management strategy. Therefore you can safely take a very high probability trade while managing risks well. Successful trading is mostly determined by how well you manage risks.
Finally, since options are leveraged, one should always try to time their entry as perfectly as possible by using shorter timeframe (hourly or 4-hour) charts, especially if the option's expiration is close. For example, you can see that the 4 hour chart for VEEV is showing momentum building back to the upside. This is what you want to see if you're going to sell a put option strategy that expires on 9/16.
These are just my thoughts and they are definitely not meant to be trading advice. As always, anything can happen. September can often be a volatile month and is prone to declines. Options trading is risky and can result in complete loss. Trade at your own risk.
If you would like me to post more strategies like this on here leave a boost or a comment below so I can gauge interest. Thank you.
If you're new to trading and don't understand the options trading language that I used above, I would recommend Project Finance to learn about options. I learned a ton about options trading from this channel and the content is always high-quality: www.youtube.com
If you want to learn more about the basics of trading, you can see my post linked below for 10 rules for successful trading.
MRNA has rallied 66% from its bottom MRNA has rallied 66% from its bottom set in mid june.
Technical indicators suggest a strong turnaround.
The P/E ratio and Forward P/E ratio remain in the low single digits.
I boosted my position when the price crossed above the 50 day EMA.
I will take advantage of any pull-back below the 200 day EMA close or low.
Overall, this is still a nice entry point if you wish to go long MRNA for the rest of the decade.